Financial & Business News

SeaStar Medical urges stockholders to vote FOR all proxy proposals prior to the Special Meeting of Stockholders to be held November 26, 2024

Saguenay, Quebec--(Newsfile Corp. - November 22, 2024) - First Phosphate Corp. (CSE: PHOS) (OTCQB: FRSPF) (FSE: KD0) ("First Phosphate" or the "Company") is pleased to announce that that it has engaged Capital Analytica ("Capital Analytica") to provide investor relations and communications services to the Company. The services will include continuing social media consultation regarding engagement and enhancement, social sentiment reporting, social engagement reporting, discussion forum monitoring and reporting, corporate video dissemination, and investor relations services.

I maintain a "Hold" rating for CrowdStrike Holdings due to its overvalued status despite strong operational performance and recovery from a significant outage. CrowdStrike's Q2 FY2025 financials exceeded expectations, with $963.8 million in revenue and $1.04 adjusted EPS, but short-term headwinds persist. Management's positive outlook for Q4 and FY2026 may drive earnings revisions higher, yet the stock's already high P/E and PEG ratios suggest overvaluation compared to peers.

ENCINO, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK ), a global business services and asset finance solutions provider, today announced that management will be participating in the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10 and 11, 2024. Management will deliver a company presentation at 12 noon ET on December 10, followed by one-on-one meetings with investors on December 11.

Micron investors have held their ground firmly above the $95 level, even as the stock has underperformed its semi-peers since peaking in June. Micron's growth prospects in the high bandwidth memory market appear robust. Nvidia must depend on its AI memory supply chain to improve its supply constraints, bolstering near-term opportunities for Micron to gain more share.

GREEN COVE SPRINGS, Fla., Nov. 22, 2024 (GLOBE NEWSWIRE) -- MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced the expansion of the Company's Board of Directors (the “Board”) to four members with the appointment of Tim Brocopp, a seasoned beverage distribution industry executive, as a new independent director, effective November 18, 2024.

With Baidu reporting a double miss for Q3 2024, BIDU stock has dipped by ~6% to a multi-year support zone in the low $80s. In Q3, Baidu's AI Cloud and Apollo Go businesses made tremendous progress, but online marketing revenue shrunk -4% y/y amid headwinds from macroeconomic factors and "Search" renovation. Baidu's long-term prospects are strong, with significant advancements in AI and autonomous driving, supported by a robust balance sheet and potential for substantial future growth.

WASHINGTON , Nov. 22, 2024 /PRNewswire/ -- Cogent Communications Holdings, Inc.("Cogent") (NASDAQ: CCOI), one of the largest Internet service providers in the world, today announced that Dave Schaeffer, Cogent's Chief Executive Officer, will present at the following conferences: The BofA Securities 2024 Leveraged Finance/Credit Conference is being held at the Boca Raton Resort in Boca Raton, FL. Dave Schaeffer will be presenting on Tuesday, December 3rd at 3:30 p.m.

ATHENS, Greece, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (NYSE: “DLNG”) (“the “Partnership”), an owner and operator of liquefied natural gas (“LNG”) carriers, today announced its results for the three and nine months ended September 30, 2024.

November 22, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Result of General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announces, announces that at its General Meeting held earlier today, both resolutions put to the Company's shareholders were duly passed. The full text of, inter alia, the resolutions proposed and passed at the Annual General Meeting and General Meeting can be found in the Notice of the General Meeting on the Company's website at: https://biodexapharma.com/investors/corporate-governance/#agms.